Winstrol 50 - Stealth Labs

Following its synthesis in the late 1950s, Stanozolol became commercially available in 1962 as Winstrol. Patented by Sterling and produced by Winthrop, it entered clinical use for various catabolic disorders. Its pyrazole ring made it structurally distinct, reducing androgenic risk and eliminating estrogenic activity. Though later removed from American pharmaceutical use, international demand preserved its production. In veterinary medicine, it became a mainstay in equine conditioning programs, where lean tissue and strength enhancement remained therapeutic priorities.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Winstrol 50 by Stealth Labs, consult with your doctor or healthcare professional.